References
- Jozan B, Kreitmann F, Bayard B. Different effects of oestradiol, oestriol, oestetrol and oestrone on human breast cancer cells (MCF-7) in long term tissue. Acta Endocrinol 1981;98:73–80
- Sasson S, Notides AC. Estriol and estrone interaction with the estrogen receptor I. Temperature-induced modulation of the cooperative binding of [3H]estriol and [3H]estrone to the estrogen receptor. J Biol Chem 1983;258:8113–17
- Sasson S, Notides AC. Estriol and estrone interaction with the estrogen receptor II. Estriol and estrone-induced inhibition of the cooperative binding of [3H]estradiol to the estrogen receptor. J Biol Chem 1983;258:8118–22
- Edwall L, Carlström K, Fianu-Jonasson A. Different estrogen sensitivity of urogenital tissue from women with and without stress urinary incontinence. Neurourol Urodynam 2009;28:516–20
- Hofling M, Carlström K, Svane G, et al. Different effects of tibolone and comntinous combined estrogen plus progestogen hormone therapy on sex hormone-binding globulin and free testosterone levels – an association with mammographic density. Gynecol Endocrinol 2005;20:110–15
- Lundström E, Christow A, Kersemaekers W, et al. Effects of tibolone and comntinous combined hormone replacement therapy on mammographic breast density. Am J Obstet Gynecol 2002;186:717–22
- Byng JW, Yaffe MJ, Jong RA, et al. Analysis of mammographic density and breast cancer risk from digitized mammograms. Radiographics 1998;18:1587–98
- Boyd NF, Lockwood GA, Byng JW, et al. Mammographic densities and breast cancer risk. Cancer Epidemiol, Biomark Prevent 1998;7:1133–44
- Lundström E, Söderqvist G, Svane G, et al. Digitized assessment of mammographic breast density in patients who received during low-dose intrauterine levonorgestrel in continuous combination with oral estradiolvalerate: a pilot study. Fertil Steril 2006;85:989–95
- Lundström E, Bygdeson M, Svane G, et al. Neutral effect of ultra low-dose continuous combined estradiol and norethisterone acetate on mammographic breast density. Climacteric 2007;10:249–56
- Söderqvist G, Poutanen M, Wickman M, et al. 17β-Hydroxysteroid dehydrogenase type 1 in normal breast tissue during the menstrual cycle and hormonal contraception. J Clin Endocrinol Metab 1998;83:1190–3
- Conner P, Svane G, Azavedo E, et al. Mammographic breast density, hormones and growth factors during contiuous combined hormone therapy. Fertil Steril 2004;81:1–7
- Woolcott CG, Kerry S. Courneya KS, et al. Association between sex hormones, glucose homeostasis, adipokines, and inflammatory markers and mammographic density among postmenopausal women. Breast Cancer Res Treat 2013;139:255–65
- Isaksson E, Sahlin L, Söderqvist G, et al. Expression of sex steroid receptors and IGF-1 mRNA in breast tissue – effects of hormonal treatment. J Steroid Biochem Mol Biol 1999;70:257–62
- Endogenous Hormones and Breast Cancer Collaborative Group. Steroid hormone measurements from different types of assays in relation to body mass index and breast cancer risk in postmenopausal women: reanalysis of eighteen prospective studies. Steroids 2015;99:49--55
- Dallal CM, Tice JA, Buist DSM, et al. for the B-FIT Research Group. Estrogen metabolism and breast cancer risk among postmenopausal women: a case–cohort study within B-FIT. Carcinogenesis 2014;35;2:346–55